top
mobile menu button
 
A+ -A Français Make a Payment
Search Arrow

INHIBIN B (National)

Test Details
Test Name : INHIBIN B
Alternative Test Names : INHIBIN B
Code: INHB
Test Overview : Used to aid in the diagnosis of granulosa cell tumors and mucinous epithelial ovarian tumors. Used for monitoring of patients with granulosa cell tumors and epithelial mucinous-type tumors of the ovary known to overexpress inhibin B. Used as an adjunct to follicle-stimulating hormone testing during infertility evaluation. Methodology is Enzyme-Linked Immunosorbent Assay (ELISA).
Test Preparation Instructions : N/A
Turnaround Time: 10 DAYS
Reference Interval:
Age Reference Interval
Sex Low High Component Low High Units Note
M 0 15 DAY 68 373 1
M 16 31 DAY 42 516 2
M 0 5 M 3
M 1 5 M 42 516
M 6 M 7 YRS 24 300 4
F 0 M 12 YRS < 183 5
M 8 30 YRS 47 383 6
F 13 41 YRS 7
F 42 51 YRS 8
F >= 52 YRS 9
M 31 72 YRS < 358 10
M > 72 YRS 11
Age
Sex Low High Component
M 0 15 DAY
M 16 31 DAY
M 0 5 M
M 1 5 M
M 6 M 7 YRS
F 0 M 12 YRS
M 8 30 YRS
F 13 41 YRS
F 42 51 YRS
F >= 52 YRS
M 31 72 YRS
M > 72 YRS

Reference Interval
Low High Units Note
68 373 1
42 516 2
3
42 516
24 300 4
< 183 5
47 383 6
7
8
9
< 358 10
11
(1)

The testing method is a
manual immunoenzymatic assay manufactured
by Ansh Labs. Values obtained
with different assay methods or kits may
be different and cannot be used
interchangeably.
If this test is being ordered as a tumor marker,
results cannot be interpreted as absolute evidence
for the presence or absence of malignant disease.

(2)

The testing method is a
manual immunoenzymatic assay manufactured
by Ansh Labs. Values obtained
with different assay methods or kits may
be different and cannot be used
interchangeably.
If this test is being ordered as a tumor marker,
results cannot be interpreted as absolute evidence
for the presence or absence of malignant disease.

(3)

The testing method is a
manual immunoenzymatic assay manufactured
by Ansh Labs. Values obtained
with different assay methods or kits may
be different and cannot be used
interchangeably.
If this test is being ordered as a tumor marker,
results cannot be interpreted as absolute evidence
for the presence or absence of malignant disease.

(4)

The testing method is a
manual immunoenzymatic assay manufactured
by Ansh Labs. Values obtained
with different assay methods or kits may
be different and cannot be used
interchangeably.
If this test is being ordered as a tumor marker,
results cannot be interpreted as absolute evidence
for the presence or absence of malignant disease.

(5)

The testing method is a
manual immunoenzymatic assay manufactured
by Ansh Labs. Values obtained
with different assay methods or kits may
be different and cannot be used
interchangeably.
If this test is being ordered as a tumor marker,
results cannot be interpreted as absolute evidence
for the presence or absence of malignant disease.

(6)

The testing method is a
manual immunoenzymatic assay manufactured
by Ansh Labs. Values obtained
with different assay methods or kits may
be different and cannot be used
interchangeably.
If this test is being ordered as a tumor marker,
results cannot be interpreted as absolute evidence
for the presence or absence of malignant disease.

(7)

Premenopausal:
Follicular: <224 pg/mL
Luteal: <80 pg/mL
Postmenopausal: <12 pg/mL
The testing method is a
manual immunoenzymatic assay manufactured
by Ansh Labs. Values obtained
with different assay methods or kits may
be different and cannot be used
interchangeably.
If this test is being ordered as a tumor marker,
results cannot be interpreted as absolute evidence
for the presence or absence of malignant disease.

(8)

Premenopausal:
Follicular: <108 pg/mL
Luteal: <80 pg/mL
Postmenopausal: <12 pg/mL
The testing method is a
manual immunoenzymatic assay manufactured
by Ansh Labs. Values obtained
with different assay methods or kits may
be different and cannot be used
interchangeably.
If this test is being ordered as a tumor marker,
results cannot be interpreted as absolute evidence
for the presence or absence of malignant disease.

(9)

Postmenopausal: <12 pg/mL
The testing method is a
manual immunoenzymatic assay manufactured
by Ansh Labs. Values obtained
with different assay methods or kits may
be different and cannot be used
interchangeably.
If this test is being ordered as a tumor marker,
results cannot be interpreted as absolute evidence
for the presence or absence of malignant disease.

(10)

The testing method is a
manual immunoenzymatic assay manufactured
by Ansh Labs. Values obtained
with different assay methods or kits may
be different and cannot be used
interchangeably.
If this test is being ordered as a tumor marker,
results cannot be interpreted as absolute evidence
for the presence or absence of malignant disease.

(11)

Not Established
The testing method is a
manual immunoenzymatic assay manufactured
by Ansh Labs. Values obtained
with different assay methods or kits may
be different and cannot be used
interchangeably.
If this test is being ordered as a tumor marker,
results cannot be interpreted as absolute evidence
for the presence or absence of malignant disease.

Specimen Requirements
Specimen Type: Serum
Container: SGT
Volume: 1.00mL

Collection Requirements: Specimen may be collected in Dr's office and submitted as per routine samples but must arrive at a Dynacare laboratory within 24 hours of collection. Samples will be frozen upon receipt in a Dynacare main lab facility. Centrifuge and aliquot serum to a transport tube. Specimen will be rejected if grossly hemolyzed.
Storage and Transport: If specimen will be received at a Dynacare main lab location within 24 hours of collection, store and ship refrigerated. If not, store frozen and ship on dry ice.

OptimalRx Plus®

Formerly known as Genecept Assay®
New name. Same trusted results.